ArticlePloS one2026
Degree of hypertension and subclinical coronary atherosclerosis in asymptomatic individuals without cardiovascular disease.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThis study sought to evaluate the association between degree of hypertension and subclinical coronary atherosclerosis. DESIGN AND
methodWe analyzed 7,332 asymptomatic individuals (mean age 52.8 ± 7.8 years; 4,680 [63.8%] men) without cardiovascular disease who voluntarily underwent coronary computed tomography angiography (CCTA) as part of a general health examination. Hypertension classification was adapted from the American College of Cardiology/American Heart Association 2025 guidelines. The degree of coronary artery disease (CAD) was evaluated using CCTA and classified as normal coronary arteries, non-obstructive CAD (diameter stenosis <50%), and obstructive CAD (diameter stenosis ≥50%).
resultsThe participants were classified into 4 groups: normal (systolic blood pressure [SBP] <120 mmHg and diastolic blood pressure [DBP] <80 mmHg; n = 2,500), elevated (SBP 120-129 mmHg and DBP < 80 mmHg; n = 969), stage 1 hypertension (SBP 130-139 mmHg or DBP 80-89 mmHg; n = 2,841), and stage 2 hypertension (SBP ≥ 140 mmHg or DBP ≥ 90 mmHg; n = 1,022). After adjusting for cardiovascular risk factors, the stage 1 hypertension group was significantly associated with non-obstructive CAD (adjusted odds ratio [aOR] 1.335; 95% confidence interval [CI], 1.156-1.541). Furthermore, the stage 2 hypertension group had a significant association with both non-obstructive CAD (aOR, 1.483; 95% CI, 1.234-1.784) and obstructive CAD (aOR, 1.696; 95% CI, 1.194-2.409).
conclusionsIn this large cross-sectional study, the degree of hypertension was associated with an increased risk and severity of subclinical coronary atherosclerosis. These findings highlight the potential importance of early recognition of blood pressure elevation and cardiovascular risk stratification in asymptomatic individuals.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.